To elucidate if the presence of fatty liver in obesity influences hepatic insulin extraction under basal conditions, serum immunoreactive insulin (IRI) and C-peptide immunoreactivity (CPR) were measured in 20 obese patients with normal glucose tolerance and in 8 normal subjects. The obese patients were subdivided into two groups matched for age and body weight according to the presence or absence of fatty liver: 8 obese patients without fatty liver (OBN) and 14 with fatty liver (OBF). Basal levels of IRI and CPRwere significantly greater in the obese patients than in the normals, but were similar in the two obese groups. In the OBFgroup, the CPR/IRI molar ratios, a relative measure of hepatic insulin uptake, were significantly lower than in the other two groups, while the ratios of the normal and OBNgroups were similar. The CPR/IRI molar ratios in all obese patients correlated well with the degree of fatty liver (r=0.785, p< 0.001). These results suggest that hepatic insulin extraction in a subgroup of obese patients is either reduced or indistinguishable from that of non-obese subjects, and that basal CPR/IRI molar ratio mayserve as a useful indicator of the presence of fatty liver in simple obesity. 
Hyperinsulinemia
in the basal state is a well-recognized feature of simple obesity. The circulating insulin level is theoretically a result of the rate of insulin secretion and of its metabolic clearance rate. However, previous results of human obesity studies on insulin metabolism at the hepatic level underlying this hyperinsulinemia have been conflicting1"4^.
Although interpretation of plasma insulin values is hampered by uncertainty
as to the extraction of hepatic insulin, simultaneous determinations of insulin and C-peptide in peripheral blood are a better reflection of endogenous insulin secretion as well as of the extent of hepatic uptake of insulin, as hepatic extraction of C-peptide is negligible5' 6^. Several investigators, however, have recently emphasized certain limitations in interpreting the C-peptide/ insulin molar ratios7\ especially under non-steady state conditions, such as those after various loading and stimulation procedures8'1°\
Obese patients are also associated with an increased incidence of fatty liverll' 12\ which may be partly related to the presence of hyperinsulinemia, because the liver is the major site of insulin metabolism. The effect of the occurrence of fatty liver on insulin metabolism has not yet been investigated in moderate obesity. Therefore, we evaluated the basal C-peptide/ insulin molar ratio in weight-matched, middleaged, moderately obese patients with normal glucose tolerance to determine whether the existence of fatty liver in obesity may or may not contribute to hepatic insulin extraction.
MATERIALS AND METHODS
Twenty obese patients were selected for this study on the basis of having a normal glucose tolerance and body mass index of greater than 30. Figure 2 shows the relationship between the degree of fatty liver and basal CPR/IRI molar ratios in obese patients. A strong correlation was noted between the liver: spleen ratios in CT numbers and basal CPR/IRI molar ratios (r=0.785, p<0.001). A relationship between the liver: spleen ratios in CT numbers and basal IRI or PG/IRI values was also found in all obese patients (r=-0.593; p<0.006, r=0.532; p<0.016, res- pectively), whereas neither basal CPRnor PG/CPR values correlated significantly with the degree of fatty liver (r=~0.038, r=-0.043, respectively).
DISCUSSION
The present study demonstrated that obese patients with hyperinsulinemia can be separated into two subgroups based on differences in insulin metabolism at the liver. Our data also confirmed previous observations of basal hyperinsulinemia and insulin resistance in the obese patients15'16^.
Our results demonstrate that reduced hepatic extraction, as assessed by CPR/IRI molar ratios, is the primary cause of hyperinsulinemia in obese patients with fatty liver, while pancreatic hypersecretion plays a lesser role. In assessing molar ratio data, the contribution of the circulating proinsulin to these hormone immunoassays should be considered.
In our patients, this contribution seemed to be negligible in obese individuals with impaired IRI/CPR ratios4^. Thus, impairment at the hepatic level, as is seen in such patients with mild insulin resistance, may be due solely to reductions in the hepatic insulin receptors16' 17'. In contrast, the CPR/IRI ratio in obese patients without fatty liver may reflect the fact that the extent of metabolic clearance at the liver is almost the same as that of normals. However, a definitive explanation for hyperinsulinemia in these patients remains unclear from this study.
Moreover, we found a strong correlation between the CPR/IRI molar ratio and the degree of fatty liver. This result supports our hypothesis that this ratio could be a useful parameter in detecting the presence of fatty liver among obese patients. In addition, this ratio in obese patients was correlated with the basal IRI, but not with the CPR level. This would agree with the report published by Rossell et al4^; although in their study the presence or absence of fatty liver was not evaluated, the possibility exists that most of their obese patients had fatty liver. 
